Effects of Nevirapine and Efavirenz on HDL Cholesterol Levels and Reverse Cholesterol Transport in Mice

OBJECTIVE: The mechanism by which non-nucleoside reverse transcriptase inhibitors (NNRTIs) increase HDL cholesterol (HDL-C) in HIV+ patients and the benefits of this with respect to cardiovascular risk are not known. Studies were conducted to test the hypothesis that NNRTIs have a beneficial effect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tohyama, Junichiro, Billheimer, Jeffrey T., Fuki, Ilia V., Rothblat, George H., Rader, Daniel J., Millar, John S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2008
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2755296/
https://ncbi.nlm.nih.gov/pubmed/18990393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2008.09.016
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge